Decoy Therapeutics closes $3.85 million warrant inducement transaction
The Houston biotech got holders to exercise Series B milestone warrants at a reduced price and issued new warrants for double the shares in exchange.
SEC filing
Latest
3 stories
Wednesday, September 23
Decoy Therapeutics closes $3.85 million warrant inducement transaction
The company induced exercise of Series B warrants at a reduced price and issued new warrants for up to 2,368,868 shares, closing September 23, 2026.
SEC filing
Friday, July 10
Decoy Therapeutics files S-1 to register 3.77 million shares from private placement warrants
The Houston biotech, formerly Salarius Pharmaceuticals, seeks to register shares underlying warrants issued in a $3.5 million private placement that closed June 29, 2026.
SEC filing